Limited utility of routine bone scintigraphy in the staging of patients with hepatocellular carcinoma: A cross-sectional study
Routine BS in HCC staging demonstrated low yield, with a notable rate of false positives. Considering the implications of extrahepatic disease, BS may be justified for liver transplant candidates outside conventional criteria. Our study highlights the limited role of BS in early-stage HCC and advocates for a more selective utilization.
Authors
- Fátima Rodríguez-Álvarez
- Alejandro Gabutti
- Graciela Castro‐Narro (ORCID: https://orcid.org/0000-0001-7511-5396)
- Eric Kauffman‐Ortega (ORCID: https://orcid.org/0000-0001-9376-906X)
- Eleazar Ignacio-Álvarez
- Carlos Moctezuma‐Velázquez (ORCID: https://orcid.org/0000-0003-2367-2742)
- Ramiro Villavicencio-Martínez
- Lucero Selene Téllez-Morán
- Blanca Zuleima Mota-Ayala
Institutions
- University of Alberta (CA)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1016/j.aohep.2024.101545
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74